Table 1. Population characteristics.
Patients | 50 |
---|---|
Age (years) | Mean : 63 (+/-9) Range : 37–84 |
Sex: | Number of patients |
- M - F |
44 6 |
Histology: | Number of patients |
- Adenocarcinoma - Squamous cell carcinoma |
28 22 |
Tumoral stage: | Number of patients |
- IIA, IIB, IIIA - IIIB |
23 27 |
Induction chemotherapy (1 to 6 cycles): | Number of patients (N) |
- Platinum salt + Pemetrexed - Platinum salt + Gemcitabin - Platinum salt + Vinorelbin - Platinum salt + Taxanes |
17 3 18 12 |
Post- induction treatment: | N |
- Concomitant chemoradiation therapy - Radiation therapy |
37 13 |
Follow-up (months) | Mean (+/- S.D.) : 21 (+/-11) Median : 19 Range : 2–45 |
Events: | N |
- Relapse - Death |
33 18 |